×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| Lasa Supergenerics Limited | 415.29 | -142.91 | 391.38 | -2.85 | 52.9 | 58.1 |
| SHELTER PHARMA LIMITED | NA | NA | NA | NA | 51.5 | 7.11 |
| TRANSCHEM LTD. | 39.86 | 7.30 | 24.24 | 0.60 | 50.7 | 9.69 |
Lasa Supergenerics Limited, with Security Code 540702, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31.7 | 35.3 | 30.6 | 24.3 | 26.7 | 22.8 | 30.8 | 39.4 | 33.1 | 39.1 |
| Expenses | 34.2 | 31.0 | 26.5 | 23.3 | 25.6 | 26.8 | 29.0 | 38.6 | 32.3 | 35.7 |
| Operating Profit | -2.5 | 4.3 | 4.1 | 1.0 | 1.1 | -4.0 | 1.8 | 0.8 | 0.8 | 3.4 |
| OPM % | -7.77% | 12.29% | 13.25% | 4.3% | 3.95% | -17.45% | 5.83% | 2.01% | 2.39% | 8.8% |
| Other Income | 0.9 | -19.0 | 0.0 | 0.1 | 0.0 | -8.8 | 0.0 | 1.9 | 8.4 | -21.5 |
| Interest | 0.4 | 0.4 | 0.4 | 0.6 | 0.4 | 0.6 | 0.9 | 1.2 | 0.5 | 0.1 |
| Depreciation | 3.1 | 4.2 | 2.7 | 2.7 | 2.7 | 2.7 | 2.8 | 2.8 | 2.8 | 3.9 |
| Profit before tax | -5.1 | 0.7 | 1.0 | -2.1 | -2.1 | -7.2 | -1.9 | -1.3 | -2.3 | 1.8 |
| Tax % | -4% | -21.9% | -580% | -98.9% | -29.4% | -4.2% | -46.6% | -145.8% | 7% | 0% |
| Net Profit | -4.9 | -15.0 | -5.0 | 0.0 | -1.5 | -15.3 | -2.7 | -3.2 | 5.5 | -14.3 |
| EPS in Rs | -1.21 | -5.98 | -0.99 | -0.29 | -3.05 | -0.55 | -0.64 | 1.1 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -9% |
| 3 Years: | -20% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -4% |
| 3 Years: | 0% |
| TTM: | -869% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -13% |
| 3 Years: | -29% |
| 1 Year: | -27% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|